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Abstract
There is an apparent overlap between areas in the USA where the herbicide, atrazine (ATZ), is heavily used and obesity-
prevalence maps of people with a BMI over 30. Given that herbicides act on photosystem II of the thylakoid membrane of
chloroplasts, which have a functional structure similar to mitochondria, we investigated whether chronic exposure to low
concentrations of ATZ might cause obesity or insulin resistance by damaging mitochondrial function. Sprague-Dawley rats
(n=48) were treated for 5 months with low concentrations (30 or 300 mgk g
21 day
21) of ATZ provided in drinking water.
One group of animals was fed a regular diet for the entire period, and another group of animals was fed a high-fat diet (40%
fat) for 2 months after 3 months of regular diet. Various parameters of insulin resistance were measured. Morphology and
functional activities of mitochondria were evaluated in tissues of ATZ-exposed animals and in isolated mitochondria.
Chronic administration of ATZ decreased basal metabolic rate, and increased body weight, intra-abdominal fat and insulin
resistance without changing food intake or physical activity level. A high-fat diet further exacerbated insulin resistance and
obesity. Mitochondria in skeletal muscle and liver of ATZ-treated rats were swollen with disrupted cristae. ATZ blocked the
activities of oxidative phosphorylation complexes I and III, resulting in decreased oxygen consumption. It also suppressed
the insulin-mediated phosphorylation of Akt. These results suggest that long-term exposure to the herbicide ATZ might
contribute to the development of insulin resistance and obesity, particularly where a high-fat diet is prevalent.
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Introduction
A close association between mitochondrial dysfunction and
insulin resistance is well established [1–3]. In in vitro studies, we
found that artificial induction of mitochondrial dysfunction
induced insulin resistance [4,5]. However, there are no in vivo
studies showing that exposure to an environmental mitochondrial
toxin causes insulin resistance.
Persistent organic pollutants (POPs) that contaminate ground
and water may accumulate in the tissues of animals and be passed
up the food chain, leading to human exposure. Some POPs have
recently been associated with the prevalence of diabetes in a serum
concentration-dependent manner [6]. The triazine herbicide,
atrazine (ATZ, 2-chloro-4-ethylamine-6-isopropylamino-S-tri-
azine), has been extensively used in the USA since the early
1960s, a time frame that corresponds to the beginning of the
present obesity epidemic [7,8]. Because it is moderately persistent
under normal soil condition and has low to moderate water-
solubility, ATZ is routinely found as a contaminant in many
surface and ground waters [9,10]. Maps of ATZ usage show that
the Corn Belt region of the Midwest USA has the heaviest
application (http://water.usgs.gov/GIS/browse/herbicide1.gif)
(supplementary Figure S1A). Interestingly, the Behavior Risk
Factor Surveillance Survey (BRFSS) from 1985 to 2005 by the
Center for Disease Control and Prevention revealed a high
concentrations of individuals with a body mass index (BMI) over
30 kg/m
2 in the Corn Belt and surroundings connected via water
sources [11] (http://www.cdc.gov/nccdphp/dnpa/obesity/trend/
maps/) (supplementary Figure S1B). ATZ-usage and obesity maps
show striking overlaps, suggesting that heavy usage of ATZ may be
associated with the risk of obesity.
ATZ binds irreversibly to the plastoquinone binding sites of
photosystem complex II on thylakoid membranes in chloroplasts,
thereby inhibiting electron transport [12]. As mitochondrial
electron transfer chain (ETC) complexes I and III also have
similar Q binding sites, we hypothesized that ATZ might bind to
these mitochondrial sites, resulting in the suppression of mito-
chondrial oxidative phosphorylation. Previous studies have shown
that exposure to ATZ reduces metabolic activity in the gills of fish
[13] and induces cellular DNA damage [14–18], tumorigenesis
[19–22], and hermaphroditism of exposed male frogs [23]. In the
present study, we found that chronic exposure to low concentra-
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rats by impairing mitochondrial function.
Materials and Methods
Animals
Male eight-week-old Sprague-Dawley rats (n=48) were treated
for 5 months with vehicle or ATZ (30 or 300 mgk g
21 day
21)
supplied in drinking water. One group of animals was fed a regular
diet for the entire period, and another group of animals was fed a
high-fat diet (40% fat) for 2 months after 3 months of a regular
diet. Initial body weights were the same in both control
(187.169.4 g) and ATZ (187.5614.0 g) groups. All rats were fed
regular chow (Han Sam R&D, Seoul, Korea) ad libitum for three
months. Then, half of each group was fed a high-fat diet (high-fat
diet group) and the other half was fed regular chow (regular-diet
group) for another two months. Regular chow consisted of 16.0%
fat, 63.0% carbohydrate and 20.0% protein (by calories), and
7.0% corn oil, 10.0% sucrose, 13.2% dextrose, 40.0% cornstarch,
5.0% cellulose and 20.0% casein (by weight). The high-fat diet
consisted of 64.0% fat, 20.0% carbohydrate and 14.0% protein (by
calories), and 33.0% shortening, 7.0% corn oil, 10.0% sucrose,
13.2% dextrose, 5.0% cornstarch, 5.0% cellulose and 20.0%
casein (by weight). The remaining percentages of the two diets
consisted of vitamins and minerals. All rats were maintained in
plastic cages in an air-conditioned room at 2262uC and 55610%
humidity. All procedures were approved by the Institutional
Animal Care and Use Committee of the Seoul National University
Hospital. The ATZ dose was calculated by multiplying ATZ
concentrations by volume of water consumed. Diet and water
consumption amounts were measured twice a month.
Measurement of activity levels
Movement was evaluated using a spontaneous motor activity
analyzer (IW-800CT, modular test chamber, Seoul, Korea).
Horizontal locomotion and rearing activity were evaluated for
4 hours per month.
Measurements of obesity
1) Body weight. The rats were weighed twice a month.
2) Visceral fat measurement by high resolution computed
tomography (CT). Visceral fat areas were quantified using non-
contrast CT scans (conditions: 120 kVp, 150 mA, 3 mm slice
thickness, 3 mm reconstruction interval) using a Somatom Sensation
16 (Siemens, Munich, Germany). With the rats in a supine position,
a 3 mm CT slice scan was acquired at the upper margin of the L3
vertebra to measure the amount of abdominal and visceral fat at a
singlelevel,andoverL1toL5forthewholeabdomen.Adiposetissue
attenuation was determined by measuring the mean value of all
pixelswithintherange of2250 to 250Hounsfieldunits.Visceral fat
amounts were measured by one radiologist using the computer
software, Rapidia (INFINITT, Seoul, Korea).
3) Intramuscular and intrahepatic lipid content by proton
magnetic resonance spectroscopy (
1H-MRS). Intramuscular
lipid (IML) and intrahepatic lipid (IHL) content was measured in
vivo by
1H-MRI, using a 3-Tesla clinical unit (Signa Excite, GE,
Milwaukee, WI, USA) with an 8-channel head coil. Voxels of
10 mm
3 were located in the anterior thigh muscles and liver,
avoiding vascular structures and gross adipose tissue deposits. A
probe-p sequence (TR/TE=2,000 ms/35 ms) was used for MRS.
Magnetic resonance imaging with the T2-weighted fast spin echo
sequences (3,000–3,500/100–120, 18-cm field of view, 2566160
matrix, 3 mm slice thickness) in the axial or coronal planes
preceded 1H-MR spectra in order to define the volume of interest.
All spectra were processed using Mrdx (CAD Impact, Inc., Seoul,
Korea), based on Interactive Data Language (Research Systems,
Inc., Boulder, CO, USA). The water signal was suppressed by a
frequency-selective saturation pulse at the water resonance value.
A sweep width of 5,000 Hz was used with a data size of 2,048
points. Only the second half of the echo was acquired. Following
the zero-filling of 8,192 points in all the free induction-decay data,
an exponential line-broadening (center 0 ms; half time 150 m) was
done before Fourier transformation. Zero-order phase correction
was applied to all spectra. The integral of the IML signal (1.3 ppm)
was related to that of total creatine (tCr; 3.05 ppm). The IML/tCr
ratio corresponded to the total muscle IML value. Fat content was
expressed as the ratio of the fat-to-water signal as a percentage.
The reliability of the method was assessed by performing repeated
measurements on the same individual on different study days and
found to be ,15%. IML and IHL content was compared between
ATZ-treated and normal groups after adjusting for weight.
Analysis of blood samples for insulin resistance and lipid
profiles
Plasma glucose levels were measured using a glucose-oxidase
method (YSI 2300-STAT; Yellow Springs Instrument Co., Inc.)
immediately after blood was drawn. Serum insulin was measured
using insulin-specific radioimmunoassay kits for rats (Linco
Research). The homeostasis model assessment-insulin resistance
(HOMA-IR) index and beta cell function (HOMA-Beta) were
obtained to evaluate insulin resistance and beta cell function. Total
cholesterol and triglyceride concentrations were determined by
enzymatic procedures (Hitachi 747 chemistry analyzer, Hitachi,
Tokyo, Japan).
Intravenous glucose tolerance test (IVGTT)
IVGTTs were performed as described [24]. All experiments were
performed during the light period between 1:00 and 2:00 pm.
Animals were food-deprived for 5 hours before starting the
experiment. To facilitate stress-free blood sampling, two infusion
catheters (PE–10, Intramedic, Clay Adams, Parsippany, NJ, USA)
were placed in the tail veins of rats on the evening before the
experiment. A bolus dose of 0.5 g glucose/kg body weight was
injected into the right tail vein immediately after blood sampling
from the left tail vein for measurement of serum concentrations of
glucose and insulin (t0). Bloodsamples were collected againfrom the
lefttail vein at 2,4,6,10, 20,30 and 60 minutes formeasurement of
serum glucose and insulin concentrations. Glucose levels were
measured using a YSI 2300 (Yellow Springs Instrument Co., Inc.,
Yellow Springs, OH, USA). Blood samples were stored at 270uC
prior to insulin measurements. Plasma insulin levels were measured
using commercial radioimmunoassay kits (Linco Research, St.
Charles, MO, USA). Areas under the curve for glucose (AUCglucose)
and insulin (AUCinsulin) were calculated using the trapezoid rule for
insulin data collected from 0 to 60 minutes.
Hyperinsulinemic-euglycemic clamp study
Hyperinsulinemic-euglycemic clamping was also performed at
the end of the study (5 months) to determine whether ATZ
exposure impaired the ability of rats to maintain glucose levels
when challenged by a high insulin load, as described [25]. Two
tail-vein infusion catheters (PE–10, Intramedic, Clay Adams) were
placed in the rats on the evening before the experiment, and one
tail-artery blood sampling catheter was emplaced 6 hours before
the start of insulin infusion. Whole-body glucose kinetics were
estimated in awake, unstressed rats 6 hours after food removal.
Patency of the arterial catheter was maintained by a slow infusion
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from the tail artery prior to the clamp study to measure baseline
fasting glucose and insulin levels. Human insulin (Novolin-R,
Novo Nordisk, Bagsvaerd, Denmark) was infused into one of the
tail vein microcatheters at a rate of 72 pmol kg
21 minute
21.
Aliquots of venous blood (50 mL) were collected from one tail vein
catheter to measure blood glucose at 10-minute intervals, and 25%
glucose was infused into the other tail vein catheter at variable
rates to maintain plasma glucose at basal concentrations. Steady-
state plasma glucose concentrations were reached after 50 to
60 minutes. Blood samples were drawn at 90 and 120 minutes for
the measurement of insulin. The steady-state glucose infusion rate
(GIR) is defined as the amount of glucose required to maintain
euglycemia between 90 and 120 minutes of hyperinsulinemia. The
insulin sensitivity index (ISI) was calculated by dividing the GIR by
the mean insulin concentration during the 90–120-minute
clamping window and expressed as mg glucose kg
21 minute
21
of for each ng/mL of insulin.
Energy expenditure
Energy expenditure in rats was measured following a 5-hour
fasting period using an Oxymax apparatus (Columbus Instru-
ments, Columbus, OH, USA) two days before each hyperinsulin-
emic euglycemic clamp experiment [26]. After baseline O2,C O 2
and flow were measured, each rat from each group was situated in
metabolic monitor cage for 10 minutes and then O2 and CO2
were measured again after the values had stabilized. Energy
expenditure was calculated according to the formula provided by
the manufacturer.
Electron microscopic images of mitochondria
At the end of the clamp, rats were euthanized with an
intravenous injection of pentobarbital, and liver and muscle tissues
were collected. The tissue samples were stored frozen at 270uC
for later analysis. Soleus muscle and liver tissues were dissected
and immersed in fixatives. Mitochondrial morphology was
examined by electron microscopy (20,0006magnification).
Western blot analysis
Cells were washed twice with Dulbecco’s phosphate buffered
saline (DPBS) and harvested with lysis buffer (50 mM Tris HCl,
pH 7.5, 0.1 M NaCl, 1 mM EDTA, 1% Triton X–100, 10 mg/mL
each aprotinin and leupeptin, 1 mM PMSF). In some cases, frozen
tissue was homogenized in lysis buffer. A portion of cell or tissue
lysate (20 mg) was separated by SDS-PAGE on 10–12% gels,
transferred to a nitrocellulose membrane (Schleicher & Schnell, Inc.,
Keene, NH, USA) and analyzed by western blotting using specific
antibodies against oxidative phosphorylation (OXPHOS) complex I
(39 kDa a subcomplex 9, NDUFA9), complex II (70 kDa flavopro-
tein, SDHA), complex III (core II, UQCRC2), complex IV-subunit I
(COXI, MTCO1), complex IV-subunit IV (COXIV, COX4) or
complex V (F1 complex a, ATP5A1). All OXPHOS complex
antibodies were purchased from Molecular Probes (Invitrogen,
Eugene, OR, USA). The antibodies against Akt and phospho-Akt
(Thr308orSer473)werepurchasedfromCellSignalingTechnology,
Inc (MA, USA). Hsp60 and/or b-actin antibodies were utilized to
control for equal loading of protein. The immunoblots were
developed using an enhanced chemiluminescence system (ECL,
Amersham Pharmacia Biotech., Arlington Heights, IL, USA).
Endogenous cellular oxygen consumption
Endogenous cellular respiration was measured as described
[27], with modifications. Briefly, isolated L6 rat skeletal muscle
cells (5610
6) in DMEM containing 0.5% FBS were cultured in the
presence of ATZ (100 mg/mL) or DMSO (vehicle control) for
48 hours, washed with DPBS (pH 7.4) and collected by trypsin-
ization. After resuspending in 1 mL complete phenol red-free
DMEM, the cells were transferred to the chamber of an
Oxygraph-2K apparatus (Oroboros, Innsbruck, Austria). Coupled
and uncoupled OCRs were measured before and after adding
2.5 mM carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone).
KCN-insensitive non-mitochondrial respiration was measured by
adding 2.5 mM KCN.
OXPHOS complex activity was measured by placing cells
(5610
6) in 1 mL of mitochondria respiration buffer (MiRO5,
20 mM HEPES, 110 mM sucrose, 3 mM MgCl2, 0.5 mM
EGTA, 10 mM KH2PO4, 60 mM K-lactobionate, 20 mM
taurine, 0.1% BSA, pH 7.1 at 30uC) into the continuously stirred
chamber of an Oxygraph-2K apparatus (Oroboros, Austria). After
recording basal respiration rate, the cells were permeabilized by
adding digitonin (25 mg/mL) and adenylate was blocked by
adding 100 mM p1,p5-di(adenosine-59)-pentaphosphate. The ac-
tivity of each OXPHOS complex was determined by sequential
addition of the following inhibitors and substrates: 2 mM ADP,
8 mM malate and 20 mM glutamate for complex I; 1 mM
rotenone, 10 mM succinate and 2.5 mM glycerol-3-phosphate
for complexes II and III; 25 mM antimycin A, 80 mM ascorbate
and 0.42 mM N,N,N,N-tetramethyl-p-phenylenediamine (TMPD)
for complex IV; and 2.5 mM KCN for KCN-insensitive
respiration. Oxygen consumption rate (OCR) was expressed as
picomoles of oxygen consumed per second per milligram of
mitochondrial protein.
Assays for mitochondrial respiratory chain activities
The OCR of complex I, complexes II and III and complex IV
of soleus muscle or liver mitochondria were measured using an
Oxygraph-2K. Mitochondria were isolated by differential centri-
fugation, as described previously [28]. Approximately 400 mg
mitochondrial protein was suspended in 1 mL MiRO5 buffer. In
some cases, isolated mitochondria were incubated with different
concentrations (0–300 mg/mL) of ATZ for 30 minutes before
OCR measurement. After recording a basal respiration rate, the
OCR of each OXPHOS complex was measured by sequential
addition of the substrates and inhibitors, as described above.
Because it is not possible to determine the activities of complex
II and complex III separately by OCR measurements, the enzyme
activities of succinate dehydrogenase (SDH, complex II) and
cytochrome bc1 complex (complex III) of the tissue or cell lysates
were assayed spectrophotometrically as described previously [29],
with slight modifications. Briefly, tissue or L6 muscle cells were
lysed in 100 mM Tris HCl (pH 7.4) containing 250 mM sucrose
and 2 mM EDTA. SDH activity was determined by reduction of
2,6-dichlorophenolindophenol (DCPIP) at 600 minus 520 nm
(extinction coefficient 19.1 mM/cm) in a mixture of 50 mM
potassium phosphate, pH 7.4, 20 mM succinate, 2 mg/mL
antimycin A, 2 mg/mL rotenone, 2 mM KCN and 50 mM
DCPIP. Complex III activity was measured by reduction of
cytochrome c at 550 minus 540 nm (extinction coefficient
19.0 mM/cm) in 50 mM Tris-HCl, pH 7.4, 250 mM sucrose,
1 mM EDTA, 0.2 mM KCN, 1 mg/mL antimycin A, 100 mM
decylubiquinol and 200 mM oxidized cytochrome c. Decylubiqui-
nol was synthesized in the laboratory from decylubiquinone by
reduction with potassium borohydride.
Complex I (NADH dehydrogenase) activity was determined in
50 mM potassium phosphate, pH 7.4, 3.5 mg/mL BSA, 0.2 mM
NADH, 1 mM antimycin A, 2 mM KCN, 70 mM decylubiqui-
none and 180 mM DCPIP by measuring the reduction of DCPIP
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[30]. Complex IV (cytochrome c oxidase) activity was determined
in 10 mM potassium phosphate (pH 7.4) with 0.1% reduced
cytochrome c (reduced by sodium hydrosulfate) by measuring
oxidation of reduced cytochrome c at 550 nm (extinction
coefficient 19.0 mM/cm) [29]. Data are expressed as percentages
of control activity.
Statistical analysis
Data are expressed as the mean6SE. Significant differences
between groups were evaluated using Student’s t tests and
ANOVA with a post hoc test. Correlations between variables
were analyzed using Pearson’s correlation coefficient. Differences
were considered statistically significant when P values were ,0.05.
Results
ATZ treatments led to weight gain
After being fed a normal diet for 3 months, control and the
ATZ-treated rats exhibited no significant differences in mean body
weight. From month 4 onward, mean body weight in the regular-
diet groups was higher for ATZ-treated rats than for control rats.
At the end of the study, the body weights of the regular-diet rats
were 582.369.3 g for the 30-mgk g
21 day
21 ATZ group (ATZ30),
585.0622.7 g for the 300-mgk g
21 day
21 ATZ group (ATZ300)
and 554.6613.4 g for controls; overall, the mean body weight of
ATZ-treated rats was 5.5% higher than that of the controls
(p,0.05; Fig. 1A and 1C). In the high-fat diet groups, the body
weights of ATZ30 and ATZ300 groups were 621.1618.8 g and
626.9616.9 g, respectively, or 9.8% higher overall than control
rats (570.8613.6 g) (p,0.01, Fig. 1B and 1C). No treatment-
related differences in food/water intake or horizontal/spontaneous
locomotor activities were observed at any point. Thus, chronic
exposure to low concentrations of ATZ resulted in weight gain,
particularly when combined with a high-fat diet.
ATZ increased visceral fat and intracellular fat content
CT scans were utilized to determine whether the weight gain
induced by ATZ was related to the amount of visceral fat. In high-
fat diet groups, ATZ-treated rats had a greater amount of visceral
fat at the L3 level and between L1 and L5 than controls (p,0.05;
n=8/group; Fig. 1D and 1E). Fat deposition in the muscle and
liver is positively correlated with measures of obesity and
negatively with insulin sensitivity [24]. Non-invasive
1H-MRS
revealed that, even in regular diet groups, ATZ treatment
increased intramuscular and intrahepatic fat accumulation, with
borderline significance after adjusting for body weight (Fig. 1F
and 1G). Thus, ATZ treatment for 5 months enhanced visceral
fat accumulation in the groups fed a high-fat diet and induced lipid
accumulation in both muscle and liver in rats fed a regular diet.
Figure 1. Induction of obesity in rats by ATZ treatment. (A and B) Changes in body weight of ATZ-treated rats (ATZ30, 30 mgk g
21 day
21;
ATZ300, 300 mgk g
21 day
21) versus control rats over time. (A) Regular-diet group. Rats were fed a regular diet for 5 months during treatment with
ATZ, provided in drinking water. (B) High-fat-diet group. Rats were fed a regular diet for 3 months and then fed a high-fat diet for another 2 months.
(C) End-of-study comparison of body weights between two different diet-treated rats. (D and E) Increase in visceral fat by ATZ. The amount of visceral
fat in the high-fat diet group was measured by horizontal CT scan. Abdominal fat area at the L3 level (D) and over L1 to L5 (E) were calculated from
the scanned image using a Hounsfield unit. (E and F) Intracellular fat deposition by ATZ. The amount of intrahepatic (F) and intramuscular (G) fat in
rats on a regular diet was measured by non-invasive
1H-MRS and adjusted for body weight. (*p,0.05, **p,0.01 vs. control).
doi:10.1371/journal.pone.0005186.g001
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For rats fed a regular diet, ATZ treatment tended to increase
triglyceride and total cholesterol levels, but the differences did not
reach statistical significance (data not shown). However, ATZ
accelerated the increase in triglycerides induced by the high-fat
diet (p,0.05 vs. control), and also worsened insulin levels and
HOMA-IR index values. Specifically, in high-fat diet groups,
insulin levels were increased to 2.3960.91 and 2.2160.86 ng/mL
in the ATZ300 and ATZ30 groups, respectively compared to
1.7060.57 ng/mL in controls (p,0.01). The corresponding
HOMA-IR values for ATZ300, ATZ30, and control groups were
0.6060.24, 0.5160.20 and 0.3760.11, respectively (p,0.05).
ATZ induced insulin resistance
To determine if ATZ treatment induced glucose intolerance and
insulin resistance, we performed IVGTTs and a hyperinsulinemic-
euglycemic clamp study. Fasting plasma glucose levels of ATZ-
treated rats on the regular diet were higher than those in controls
(86.569.8, 91.168.5, and 78.568.3 mg/dL in ATZ30, ATZ300
and controls, respectively; p,0.05), although they were within the
normal range. The same pattern was found in the high-fat diet
group: fasting glucose levels were 97.866.5 and 10268.3 in ATZ30
and ATZ300 groups, respectively, compared to 90.066.7 mg/dL
in controls (p,0.05). Interestingly, ATZ exposure impaired glucose
tolerance as monitored by IVGTT. Plasma glucose and insulin
concentrations in both ATZ-treated groups were significantly
higher than those in controls at early points (,10 min) after
intravenous loads of glucose (p,0.05 vs. control) (Fig. 2A and 2B).
The hyperinsulinemic-euglycemic clamp study demonstrates an
animal’s ability to maintain glucose levels when challenged by a
high insulin load. Steady-state plasma insulin concentrations were
measured as plasma glucose reached steady state during clamping.
For the ATZ-treated rats on a regular diet, insulin levels increased
Figure 2. Impairment of IVGTT and insulin sensitivity by ATZ exposure in regular-diet rats. (A) Changes in plasma glucose during IVGTT.
(B) Changes in plasma insulin during IVGTT. Plasma glucose or insulin concentrations were determined at the indicated times after i.v. glucose load.
(C) Steady-state glucose infusion rate (GIR) and (D) insulin sensitivity index (ISI) during clamp study. (*p,0.05 vs. control; n=8 per group).
doi:10.1371/journal.pone.0005186.g002
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ATZ300 compared with 4.9060.60 ng/mL glucose infusion rate
for controls (p,0.05 for both). AZT significantly decreased the
steady-state glucose infusion rate (GIR) during the clamp to
31.562.22 and 32.7563.18 mg kg
21 minute
21 for ATZ30 and
ATZ300, respectively compared to 41.1362.28 mg kg
21 mi-
nute
21 for controls (p,0.05 for both) (Fig. 2C). Thus, the
ATZ-exposed rats showed an impaired response to insulin loading,
even under a regular diet. The insulin sensitivity index (ISI) was
also significantly reduced to 4.260.17 for ATZ30 and 4.560.23
for ATZ300 compared with 6.160.15 for controls (p,0.05 for
both; Fig. 2D). Collectively, these data support the conclusion
that rats chronically exposed to ATZ developed insulin resistance
without being fed a high-fat diet.
ATZ changed the ultrastructure of mitochondria
The soleus muscles of ATZ-treated rats were not discernibly
different from those of control rats by light microscopy. However,
electron microscopy showed that soleus muscle mitochondria in
these animals on a regular diet were swollen and their cristae were
partially destroyed (Fig. 3A). There was also prominent accumu-
lation of lipid droplets in the livers of ATZ-treated rats, and electron
microscopy revealed that some liver mitochondria from the ATZ-
treated group showed partially disrupted cristae. Despite the fact
that mitochondrial morphology was altered in muscle and liver by
ATZ administration, protein expression levels of mitochondrial
OXPHOS complex subunits in liver and muscle tissues were not
changed significantly (Fig. 3B). Therefore, the AZT-induced
disruption of mitochondrial morphology might not be associated
with changes in mitochondrial complex protein expression.
ATZ exposure decreased energy metabolism
Insulin resistance and obesity are affected by caloric intake,
physical activity and energy expenditure [31,32]. Since no
treatment-related changes in food or water intake or physical
activity were observed at any point during the study, the
development of insulin resistance by ATZ might be related to
energy metabolism. To determine if ATZ affected energy
metabolism, we measured energy expenditure and OCR using
indirect calorimetry and oxygen sensors, respectively. The energy
expenditure of ATZ-treated rats on regular diet was reduced in a
dose-dependent manner (Fig. 4A). The OCR of each OXPHOS
complex was measured using mitochondria isolated from the
soleus muscle of ATZ-treated rats on regular diet. The combined
OCR measured for complexes II plus III, both of which use
ubiquinone (Q) as an electron transfer intermediate, was
significantly reduced by ATZ administration. The activities of
other complexes were not altered (Fig. 4B), although the OCR of
complex I showed a tendency toward a decrease that did not reach
statistical significance. There were some analytical limitations in
measuring OCR where the changes were modest, especially when
using animal tissues.
To distinguish which of these complexes (II or III) were affected
by ATZ, we measured the enzymatic activities of SDH (complex
II) and cytochrome bc1 (complex III) in gastrocnemius muscle
tissues by spectrophotometry. As expected, SDH activity was not
altered by ATZ treatment while the activity of the cytochrome bc1
complex was decreased by 10% in the muscles of ATZ-treated
animals (p,0.05, Fig. 4C). These results suggest that ATZ may
bind to the Q site of the cytochrome bc1 complex, a counterpart of
the plastoquinone of photosynthesis in plants. Consistent with
tissue lysate western blotting results, the amounts of OXPHOS
complex proteins in mitochondria were not significantly altered.
The western blot results imply that ATZ might interfere with the
electron transfer from complex I or II to complex III without
impacting mitochondrial OXPHOS protein expression levels
(Fig. 4D). However, we cannot exclude the possibility that the
expression of other proteins that were not examined by western
blotting might be involved in changes in mitochondria respiration
activity.
ATZ impairs mitochondrial OXHPOS through direct
action
Changes in cellular respiration and differences in the respiratory
effects of inhibitors are important indicators of mitochondrial
functional defects that result from damaged mitochondrial
proteins or DNA (mtDNA), or substantial alterations to mito-
chondrial signaling cascades. To test if ATZ impaired mitochon-
drial function directly or indirectly, we monitored both cellular
and mitochondrial respiration levels in ATZ-treated, cultured L6
muscle cells and isolated mitochondria. Incubation of L6 muscle
cells with ATZ decreased both endogenous coupled and FCCP-
uncoupled oxygen consumption by 30% and 40%, respectively
(Fig. 5A). ATZ had no effect on the levels of nuclear DNA
(nDNA)- or mtDNA-encoded OXPHOS complex proteins
(Fig. 5B). When oxygen consumption was measured using
digitonin-permeabilized cells, respiration levels in complex II plus
III were inhibited by ATZ (Fig. 5C), similar to the in vivo results
(see Fig. 4C). Enzyme activities of complex III (cytochrome bc1)
were also decreased by ATZ treatment (Fig. 5D). Direct
treatment of isolated mouse liver mitochondria with ATZ also
reduced the OCR of complex I and complex II plus III by 49%
and 37%, respectively (Fig. 6A); the magnitude of these ATZ
effects were greater in isolated mitochondria than in cells.
Complex IV activities were not significantly changed. Again,
consistent with the results of the in vivo study, SDH enzymatic
activity was not changed, but the activity of the cytochrome bc1
complex was decreased significantly by ATZ treatment (Fig. 6B).
These results strongly suggest that ATZ itself, not ATZ
metabolites, intervenes directly at Q binding sites between
complex I and III, or II and III.
ATZ treatment blocked the insulin-Akt signaling pathway
To investigate the mechanism by which ATZ-induced mito-
chondrial dysfunction caused insulin resistance, we analyzed
insulin-stimulated Akt phosphorylation in ATZ-treated L6 muscle
cells. Pretreatment with ATZ (100 mg/mL) for 24–48 hours
abolished insulin-mediated Akt phosphorylation at both Thr308
and Ser473 residues (Fig. 7). Park et al. demonstrated that
mitochondrial dysfunction induced by mtDNA depletion sup-
pressed IRS-1 expression, resulting in diminished downstream
signaling and glucose transport, and insulin resistance [5]. The
suppression of insulin-mediated Akt phosphorylation is clearly
linked to the development of insulin resistance in vitro [33] and in
vivo [34]. Thus, the reduction in Akt phosphorylation that results
from ATZ-mediated inhibition of mitochondrial OXPHOS
complex III may help to explain why chronic exposure to ATZ
induced weight gain and insulin resistance.
Discussion
In this study, we found that long-term treatment with low
concentrations of the herbicide, ATZ, induced insulin resistance
and weight gain in Sprague Dawley rats. We acknowledge that,
unlike the current results, previous studies have reported that the
body weights of ATZ-treated animals were generally decreased or
unchanged [35–37]. However, the doses of ATZ used in these
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exposure to high concentrations of ATZ is toxic, and thus prevents
weight gain and possibly causes weight loss. In contrast, chronic
low-dose ATZ exposure might lead to mild mitochondrial damage
that mimics the characteristic of the insulin-resistance state, and
hence, leads to weight gain.
Because ATZ treatment in our study induced obesity without
changing food intake or physical activity, ATZ presumably lowered
energy metabolism. Indeed, indirect calorimetry measurements
revealed that the ATZ-induced weight gain was associated with
decreased energy metabolism. Furthermore, in vitro experiments
provided evidence that ATZ interferes with electron transfer
through OXPHOS complex at Q sites in mitochondria, resulting
in reduced oxygen consumption. We have found that treatment
with rotenone, a complex I inhibitor, or dideoxydytidine, an
mtDNA-replication inhibitor, directly inhibits insulin-mediated
Figure 3. Mitochondrial morphology and protein expression in ATZ-treated rat muscle and liver. (A) Mitochondrial morphology by
electron microscopy. Rats on a regular diet were treated with or without ATZ300 for 5 months. Rat soleus muscle and liver were isolated and
observed by electron microscopy (magnification 620,000). Enlarged, swollen or cristae-disrupted mitochondria are indicated by arrows. Lipid
droplets were observed in ATZ-treated liver. (B) Expression of mitochondrial proteins in rat tissues. Total lysates of soleus muscle or liver of rats on a
regular diet with or without ATZ treatment were analyzed by western blotting using the indicated antibodies.
doi:10.1371/journal.pone.0005186.g003
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molecules (data not shown). In addition, overexpression of
dominant-positive Akt (myr-Akt) completely reverses downstream
Akt function. For example, Akt-mediated phosphorylation of
Foxo1, which is blocked by mitochondrial dysfunction, is abrogated
by myr-Akt overexpression, implying that Akt is the focal point of
the mitochondrial dysfunction (manuscript in preparation). As part
of this study, we tested whether ATZ also blocked Akt function, and
found, as expected, that ATZ blocked insulin-mediated Akt
phosphorylation in skeletal muscle cells.
Treatment with ATZ changed the ultrastructure of mitochon-
dria in liver and muscle of rats, producing morphological
alterations such as ring- and cup-shaped mitochondria without
significantly altering the expression of mitochondrial OXPHOS
complex proteins. This observation is in agreement with the
findings of others that ATZ induced mitochondrial damage in
fresh water mussels [13] and rainbow trout [38]. In our study, we
also found that ATZ decreased the membrane potential of
mitochondria and reduced intracellular ATP content in various
cells (data not shown). Collectively, these data led us to conclude
that ATZ treatment damaged both mitochondrial respiratory
function and morphology.
Intramuscular lipid accumulation is known to be closely related
to insulin resistance [39,40], and is considered as an early
phenomenon in the development of obesity. Increased lipid
content in muscle is also associated with decreased ATP synthesis
and diminished mitochondrial function [1]. The observed increase
in intracellular lipid content in ATZ-treated rats also supports the
interpretation that ATZ-induced mitochondrial damage affects the
insulin-signaling pathway, and consequently induces insulin
resistance and fat accumulation in metabolically active tissue,
such as muscle.
There is epidemiological evidence that human exposure to
POPs such as TCDD may also disturb glucose metabolism and
induce insulin resistance [6,41–47], and it has been reported that
exposure to herbicides or pesticides, including ATZ, is associated
with an increased risk of gestational diabetes [47]. However, there
is scant information in the literature to indicate the level of human
exposure to ATZ or similar herbicides. Obviously, there is no
direct evidence of ATZ accumulation in diabetic or obese human
subjects. However, a toxicological report has shown that acute
occupational or dietary exposure of humans to ATZ was in the
range of 0.2–90 mgk g
21 day
21, and the annual average exposure
(chronic) was between 0.046 and 0.286 mgk g
21 day
21 [48].
Figure 4. Mitochondrial OXPHOS activity of ATZ-treated rat skeletal muscle mitochondria. Rats on a regular diet were treated with or
without ATZ for 5 months. (A) Dose-dependent decrease in energy expenditure in ATZ-treated rats, monitored using indirect calorimetry. (B)
Decrease in OCR of complex II plus III in ATZ300-treated skeletal muscle mitochondria (n=5). (C) Decrease in the activity of complex III enzyme in
ATZ-treated liver lysates, determined by spectrophotometry (*p,0.05, **p,0.01; n=5). (D) Western blot of muscle mitochondria proteins. Total
skeletal muscle mitochondrial lysates from rats on a regular diet were subjected to western blot analysis using the indicated antibodies.
doi:10.1371/journal.pone.0005186.g004
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PLoS ONE | www.plosone.org 8 April 2009 | Volume 4 | Issue 4 | e5186Figure 5. Decrease in endogenous oxygen consumption by ATZ in L6 cells. L6 rat skeletal muscle cells were treated for 48 hours with or
without ATZ (100 mg/mL). (A) Endogenous cellular (coupled), FCCP-uncoupled (FCCP) and KCN-insensitive respiration (KCN) of trypsinized intact cells
were measured in phenol red-free media using an Oxygraph-2K apparatus (*P,0.05; n=3). (B) Western analysis of nDNA- and mtDNA-encoded
OXPHOS complex subunit proteins. Complex I (ND9), complex II (SDHA), complex III (UQCRC2) and complex IV (COXI, mtDNA-encoded, COXIV, nDNA-
encoded) were examined. b-actin was used as an equal loading control. (C) Oxygen consumption by each complex in digitonin-permeabilized cells
was measured using an Oxygraph-2K apparatus (P,0.05; n=4). (D) Enzyme activities of complex II or III were determined by spectrophotometry in
ATZ-treated L6 muscle cells (*P,0.05; n=3).
doi:10.1371/journal.pone.0005186.g005
Figure 6. Inhibition of complex I and II plus III in isolated mitochondria by ATZ. (A) OCR. Mouse liver mitochondria (40 mg/100 mL assay)
isolated by differential centrifugation were incubated with ATZ (100 mg/mL) for 30 minutes and the OCR of each complex was measured. (B) Enzyme
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humans through air, water and and/or corn products as
contaminants, and accumulate in tissues. One such pathway by
which ATZ or its metabolites might be introduced into humans is
through corn-derived foods (e.g., high fructose corn syrup or corn
oil). Since corn syrup [49] and fast foods served in the USA [50,51]
are suspected of causing an obesity epidemic, this seems a
reasonable supposition. Recently, it was reported that of 160 food
products purchased at a fast food restaurant throughout the USA,
not a single item could be traced back to a non-corn source [52].
This work also identified corn as the overwhelmingly predominant
animal feed for the beef and chicken served at fast food restaurants.
Considering that the process of corn wet milling requires a huge
amount of fresh water for steeping (digesting), which in turn
generates 1,300 to 1,600 L of light steepwater per ton of corn that
is then evaporated or dried to make intermediate products, it is
conceivable that ATZ and related herbicides are present in
steepwater and may be concentrated during the process [53].
Because herbicides like ATZ and their metabolites are present in
streams and groundwaters throughout USA and are at highest
concentrations in agricultural areas where wet corn milling plants
are located [54], there is a substantial possibility of ATZ
contamination of corn products. However, in 2006 the U.S.
Environmental Protection Agency issued a cumulative risk
assessment of triazine herbicides, concluding that they posed ‘‘no
harm that would result to the general U.S. population, infants,
children, or other consumers’’ [55].
Based on evidence presented in this study, we conclude that
environmental ATZ might be an important contributing factor to
the obesity epidemic in the United States. It damages mitochon-
drial function, affects insulin signaling, and induces insulin
resistance and obesity, especially when exposure is associated with
a high-fat diet. Sanguine official assessments notwithstanding,
further studies are definitely needed to clarify issues related to
human exposure to ATZ and related herbicides in the US and
elsewhere around the world.
Supporting Information
Figure S1 Comparison of atrazine usage map and obesity trend
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